Skip to content

Clinical trials

Phase 1/2 Papillomavirus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Papillomavirus Infections Phase: Phase 1/2 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20161
20171
20181
20212
20231
20242
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Not yet recruiting4
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abramson Cancer Center at Penn Medicine1
Anaconda Pharma1
Antiva Biosciences1
Barinthus Biotherapeutics1
Beijing 302 Hospital1
Cellid Co., Ltd.1
Janssen Vaccines & Prevention B.V.1
MGB Pharma1
Marengo Therapeutics, Inc.1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Papillomavirus Infections13
Condylomata Acuminata2
Sexually Transmitted Diseases2
Uterine Cervical Neoplasms2
Vulvar Diseases2
Vulvar Neoplasms2
Abdominal Neoplasms1
Basal Cell Carcinoma1
Biliary Tract Neoplasms1
Carcinoma1

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.